The Swiss market maintains a robust and innovation-driven medical devices sector, closely aligned with European standards but governed by its own national legislation. Since the end of the Mutual Recognition Agreement in 2021, Switzerland now requires third country manufacturers, non-Swiss manufacturers, to fulfill Swiss-specific obligations to maintain market access within its high-quality healthcare system., including appointment of a Swiss Authorised Representative (CH-REP) and device registration with Swissmedic.